Tag: teva
Gilead, Teva Strike Last Minute Deal Over Generic Delay Of HIV...
The antitrust trial involving Gilead and Teva over inflated HIV drug prices is set to begin on Thursday. However, the two drugmakers reached a...
Gilead And Teva’s HIV Antitrust Trial Begins
Gilead Sciences and Teva Pharmaceutical Industries have a long history of defending themselves against allegations of colluding to hinder competition to Gilead's profitable lineup...
Amgen, Teva Get Can Appeal Sensipar Antitrust Ruling
Amgen and Teva Pharmaceuticals Industries have been granted permission for an expedited appeal in an antitrust case related to Amgen's Sensipar, a calcium reducer,...
Judge Narrows Antitrust Case Against Teva Over Gilead HIV Drugs
Teva Pharmaceutical Industries succeeded in scaling back its potential antitrust exposure for allegedly helping delay generic versions of Gilead Sciences's blockbuster HIV drugs, when...
Teva Reaches Settlement With Mississippi In Price-Fixing Case
After years of facing allegations of price-fixing on a massive scale, Teva Pharmaceuticals has agreed to settle with the state of Mississippi for US$925,000....
Teva To Pay $1.1M In Intuniv Antitrust Settlement
Teva Pharmaceutical Industries has agreed to pay US$1.1 million to settle antitrust claims by buyers of Shire's ADHD drug Intuniv, who accused Shire and...
EU Probes Teva For Blocking Rivals To Multiple Sclerosis Drug
Israeli drugmaker Teva is being investigated by EU antitrust regulators who are looking into whether it illegally hindered rivals' access to its multiple sclerosis...
EU Watchdog Probes Teva Over Copaxone Drug
EU antitrust regulators on Thursday, March 4, opened a formal investigation into whether Israeli drugmaker Teva illegally hindered rivals to its multiple sclerosis medicine...
New Mexico Opens Suit Against Gilead, Bristol-Myers, Teva Over HIV Meds
Gilead Sciences, Bristol-Myers Squibb, Gilead Sciences, and Teva Pharmaceuticals were named in a lawsuit filed by New Mexico Attorney General Hector Balderas for violating...
EC Fines Teva & Cephalon €60.5M
The European Commission has fined the pharmaceutical companies Teva and Cephalon €60.5 million (US$72.1 million) for agreeing to delay for several years the market...
